In November 2018 we received FDA approval of Sympazan™ (clobazam) Oral Film. Sympazan is a film formulation of clobazam, a benzodiazepine used as an adjunctive therapy for seizures associated with Lennox-Gastaut syndrome (LGS).
For full Prescribing Information, including Boxed Warning on the risks of concomitant use with opioids, click here.
Please see full Prescribing Information, including Boxed Warning.
Aquestive has also demonstrated a strong track record of developing and manufacturing products for commercial partners. Aquestive works hand-in-hand with our partners to address their toughest challenges—enhancing existing molecules and providing a development platform for new ones. Strategic partnerships are at the core of our business, whethercompanies want to leverage our PharmFilm technology for existing treatments that are in development or on the market. We are proud of our strong track record of more than 5 active partnerships and a product portfolio that has generated billions of dollars in revenue.
PharmFilm Marketed Products
Treatment of Opioid
Treatment of Nausea
The first and only FDA approved film formulation of clobazam.Click here to learn more Please see full prescribing information, including BOXED WARNING